PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma

Table 2

Correlation analysis between PLEKHA4 and biomarkers of immune cells in glioma detected by GEPIA database.

	Biomarker	value	value
CD4+ T cell	CD4	0.32	0
CD8+ T cell	CD8A	0.25
	CD8B	0.19
B cell	CD19	0.16
	CD79A	0.059	0.13
Neutrophil	CEACAM8	0.032	0.41
	ITGAM	0.29
	CCR7	0.15
Dendritic cells	HLA-DPB1	0.40	0
	HLA-DQB1	0.33	0
	HLA-DRA	0.37	0
	HLA-DPA1	0.36	0
	CD1C	0.076	0.046
	NRP1	0.34	0
	ITGAX	0.27
NK cells	KIR2DL1	0.091	0.018
	KIR2DL3	0.079	0.039
	KIR2DL4	0.26
	KIR3DL1	0.11	0.0028
	KIR3DL2	0.16
	KIR3DL3	-0.0043	0.91
	KIR2DS4	0.049	0.2
M1 macrophage	NOS2	0.16
	IRF5	0.36	0
	PTGS2	0.15
M2 macrophage	CD163	0.25
	VSIG4	0.20
	MS4A4A	0.21
Mast cells	TPSB2	0.00049	0.99
	TPSAB1	0.048	0.21
	CPA3	0.037	0.34
	HDC	0.15	0.00011
Th1	T-bet	0.3
	STAT4	-0.13	0.00042
	TNF-a	0.02	0.6
Th2	GATA3	0.16
	STAT6	0.27
	STAT5A	0.5	0
	IL13	0.063	0.099
Th17	STAT3	0.45	0
	IL17A	0.061	0.11
Tfh	BCL6	-0.032	0.41

value < 0.05; value < 0.01; value < 0.001.